On February 4, 2020, the Yield Growth Corporation announced that Patent Lawyer, Charles Boulakia was appointed to the Flourish Mushroom Labs Advisory Board. According to the press release Mr. Boulakia …
Recently, Compass Pathways issued a press release stating “that it has been granted US Patent No 10,519,175 (“the ‘175 patent”), relating to methods of treating drug-resistant depression with a psilocybin …
Investing in psychedelics (e.g., magic mushrooms, psilocybin, etc.) has became a hot topic during 2019. Following Peter Thiel’s investment in Compass Pathway in 2018, several high-profile investors entered the psychedelic …
Yield Growth subsidiary Flourish Mushroom Labs appears to have discovered a fundamentally new use for the active compounds in magic mushrooms, i.e. psilocin and its prodrug psilocybin. On December 10, …
Based on newfound benefits of magic mushrooms and the changing cultural (and legal) climate, some early movers have started working on psilocybin containing consumer products, like foods and beverages. On …
On May 17, 2019, Wuhan General Group (“Wuhan”) announced signing a Letter of Intent (“LOI”) with Biodelta Nutraceuticals, Ltd. This announcement follows Wuhan’s April 5, 2019 announcement that its wholly-owned …
In late April of 2019, both the United States Patent and Trademark Office (“USPTO”) and the World Intellectual Property Office (“WIPO”) published Compass Pathways’s Patent Applications directed to psilocybin technology. …
** See also recent article on “Investing in Psychedelics – a 2020 Perspective” ** [Updated December 2019] Are magic mushrooms (or psilocybin) going to be the next big investment opportunity …
The scientific community universally agrees that psilocybin and/or magic mushrooms have enormous potential for treating some of the world’s biggest health problems. Furthermore, scientists agree that psychedelics (like magic mushrooms, …
Recent developments in science and policy reform suggest that “magic mushrooms” and psilocybin technology will evolve into a psilocybin industry. Investments by several early movers illustrate that a psilocybin industry …
